Neuropozyne
Neuropozyne is a drug that features in Deus Ex.
Contents |
History
Neuropozyne was created by Darrow Industries, in order to address the aforementioned rejection syndrome, made more severe in the wake of the PEDOT revolution ushered in around 2010. Darrow sold his exclusive patent for Neuropozyne to Bob Page's VersaLife in 2020, which used its monopoly to turn Neuropozyne a multi-billion dollar source of revenue. As Neuropozyne was not manufactured using rare chemicals, the monopoly was upheld by strictly monitoring distribution and jealously protecting trade secrets surrounding its synthesis
Overview
Mechanical augmentations were sophisticated pieces of machinery that require a human-machine interface to function, as designed. The standard design was Darrow Industries' PEDOT-cluster array, where polymer electrodes bridged augs and the host's neurons, acting as a neuroprosthetic junction. PEDOT clusters connected to a biochip, which in turn interfaced with the host's brain directly. Unlike conventional, non-cybernetic implants, the invasive nature of the augmentations causes the body to identify them as a foreign object and triggers an immune response: Glial tissue begins to form around PEDOT clusters, leading to what's best described as nerve scars. The glial tissue buildup eventually shuts the augs down and culminates in an extremely dangerous implant rejection, identified as the Darrow Deficiency Syndrome. Neuropozyne is a drug developed to control the body's rejection response, breaking down glial tissue build-ups and preventing further build up of the tissue until Neuropozyne is metabolized. A standard dose was enough for one week of protection.
Users
- Adam Jensen :
Notes
- Neuropozyne was created by Mary DeMarle where it featured in the setting of the Deus Ex universe.
Appearances
- Deus Ex: Human Revolution:
External Links
This article is a stub. You can help Multiversal Omnipedia by expanding it.
